These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 23859341)

  • 1. Mitochondrial pathophysiology in Friedreich's ataxia.
    González-Cabo P; Palau F
    J Neurochem; 2013 Aug; 126 Suppl 1():53-64. PubMed ID: 23859341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Friedreich's ataxia: clinical aspects and pathogenesis.
    Pandolfo M
    Semin Neurol; 1999; 19(3):311-21. PubMed ID: 12194387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of frataxin in fission yeast iron metabolism: implications for Friedreich's ataxia.
    Wang Y; Wang Y; Marcus S; Busenlehner LS
    Biochim Biophys Acta; 2014 Oct; 1840(10):3022-33. PubMed ID: 24997422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two different pathogenic mechanisms, dying-back axonal neuropathy and pancreatic senescence, are present in the YG8R mouse model of Friedreich's ataxia.
    Mollá B; Riveiro F; Bolinches-Amorós A; Muñoz-Lasso DC; Palau F; González-Cabo P
    Dis Model Mech; 2016 Jun; 9(6):647-57. PubMed ID: 27079523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron Pathophysiology in Friedreich's Ataxia.
    Li K
    Adv Exp Med Biol; 2019; 1173():125-143. PubMed ID: 31456208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction in neurons in Friedreich's ataxia.
    Stepanova A; Magrané J
    Mol Cell Neurosci; 2020 Jan; 102():103419. PubMed ID: 31770591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
    Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P
    Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Friedreich's ataxia: pathology, pathogenesis, and molecular genetics.
    Koeppen AH
    J Neurol Sci; 2011 Apr; 303(1-2):1-12. PubMed ID: 21315377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Friedreich's ataxia: the vicious circle hypothesis revisited.
    Bayot A; Santos R; Camadro JM; Rustin P
    BMC Med; 2011 Oct; 9():112. PubMed ID: 21985033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.
    Anzovino A; Lane DJ; Huang ML; Richardson DR
    Br J Pharmacol; 2014 Apr; 171(8):2174-90. PubMed ID: 24138602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches.
    Schmucker S; Puccio H
    Hum Mol Genet; 2010 Apr; 19(R1):R103-10. PubMed ID: 20413654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.
    Gomes CM; Santos R
    Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Prospects for Friedreich's Ataxia.
    Zhang S; Napierala M; Napierala JS
    Trends Pharmacol Sci; 2019 Apr; 40(4):229-233. PubMed ID: 30905359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
    Abeti R; Parkinson MH; Hargreaves IP; Angelova PR; Sandi C; Pook MA; Giunti P; Abramov AY
    Cell Death Dis; 2016 May; 7(5):e2237. PubMed ID: 27228352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferiprone for the treatment of Friedreich's ataxia.
    Pandolfo M; Hausmann L
    J Neurochem; 2013 Aug; 126 Suppl 1():142-6. PubMed ID: 23859349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia.
    Chiang S; Kovacevic Z; Sahni S; Lane DJ; Merlot AM; Kalinowski DS; Huang ML; Richardson DR
    Clin Sci (Lond); 2016 Jun; 130(11):853-70. PubMed ID: 27129098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia.
    Auchère F; Santos R; Planamente S; Lesuisse E; Camadro JM
    Hum Mol Genet; 2008 Sep; 17(18):2790-802. PubMed ID: 18562474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friedreich's ataxia: past, present and future.
    Marmolino D
    Brain Res Rev; 2011 Jun; 67(1-2):311-30. PubMed ID: 21550666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Friedreich's ataxia: from disease mechanisms to therapeutic interventions.
    Lodi R; Tonon C; Calabrese V; Schapira AH
    Antioxid Redox Signal; 2006; 8(3-4):438-43. PubMed ID: 16677089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.